Opinion|Videos|July 23, 2024
Patient with R/R CLL Treated with 2L Venetoclax Therapy
A hematology and oncology specialist presents the case of a 66-year-old man with chronic lymphocytic leukemia.
Advertisement
Episodes in this series
Video content above is prompted by the following questions:
- Please present your clinical case of an elderly patient with R/R CLL who receives second-line fixed-duration therapy with venetoclax.
- Please describe your initial impressions of this case. How might you have treated this patient in your practice?
Advertisement
Related to this article
CHMP recommends pirtobrutinib for CLL across all treatment lines after phase 3 trials showed strong efficacy and a favorable safety profile.
Advertisement
Advertisement
Trending on OncLive
1
ctDNA MRD Status Predicts OS Benefit With Adjuvant Chemotherapy in Resected CRC Liver Metastases
2
How Bispecific T-Cell Engager Therapy Works and Why HLA Status Is Non-Negotiable
3
FDA Accepts NDA for Varegacestat in Desmoid Tumors
4
Cracking the KRAS Code: How Daraxonrasib Is Reshaping Pancreatic Cancer and Beyond
5